HomeVTYX • NASDAQ
add
Ventyx Biosciences Inc
Previous close
$1.21
Day range
$1.20 - $1.41
Year range
$0.78 - $5.66
Market cap
99.63M USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.10M | -27.94% |
Net income | -27.44M | 28.86% |
Net profit margin | — | — |
Earnings per share | -0.39 | 37.10% |
EBITDA | -30.00M | 28.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 228.81M | -24.38% |
Total assets | 253.48M | -23.67% |
Total liabilities | 21.85M | -12.90% |
Total equity | 231.63M | — |
Shares outstanding | 71.16M | — |
Price to book | 0.37 | — |
Return on assets | -28.39% | — |
Return on capital | -29.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -27.44M | 28.86% |
Cash from operations | -25.72M | 46.00% |
Cash from investing | 26.42M | -36.75% |
Cash from financing | — | — |
Net change in cash | 816.00K | -99.10% |
Free cash flow | -15.31M | 52.24% |
About
Founded
2018
Website
Employees
81
